Related Experiment Videos
Morphine: myths, morality and economics
1St Columba's Hospice, Edinburgh.
Postgraduate Medical Journal
|January 1, 1991
Summary
Morphine, a crucial pain reliever, is inaccessible to billions, leading to needless suffering for cancer patients. Improved availability and education are vital for effective pain management worldwide.
Area of Science:
- Palliative Care
- Pain Management
- Public Health
Background:
- Morphine is essential for cancer pain relief, yet its availability is severely limited globally.
- An estimated 1.3 to 2.5 billion people lack access to essential pain medication.
- 3.5 million cancer patients suffer unnecessarily due to inadequate pain management.
Purpose of the Study:
- To highlight the critical issue of morphine unavailability.
- To identify barriers to morphine access and appropriate use.
- To advocate for improved global morphine availability and prescribing practices.
Main Methods:
- The abstract does not specify methods but discusses global availability and prescribing patterns.
- It analyzes consumption trends of morphine and codeine in various countries.
- It identifies persistent fears and educational deficits as key issues.
Main Results:
- Morphine consumption is rising in only 10 countries.
- Codeine consumption is increasing in many regions, but not universally.
- Prescribing remains limited in many Western countries, influenced by addiction fears and inadequate professional education.
Conclusions:
- There is a significant global tragedy of morphine unavailability impacting millions of cancer patients.
- Barriers include persistent fears of addiction, minimal professional education in analgesia, and overemphasis on expensive administration methods.
- Physicians have a moral and professional duty to advocate for accessible, economical, and effective morphine formulations globally.